Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to firstname.lastname@example.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 14 August 2014 | By Alexander Gaffney, RAC,
The US Food and Drug Administration (FDA) is seeking a new director for the Center for Drug Evaluation and Research's (CDER) Office of Medical Policy (OMP).
The position has previously been held by FDA's Rachel Sherman, and is now held by Acting Director Capt. Denise Hinton. The 150-person office is influential within FDA, and describes itself as the "driving force" behind drug policy development at the agency. Hinton's agency profile notes that the office is involved with developing a new policy on biosimilars development, among other initiatives.
OMP also oversees the Office of Prescription Drug Promotion (OPDP), which regulates all pharmaceutical advertising in the US.
FDA's job posting announcements indicate the agency is looking for someone with extensive experience in legal and regulatory policy, as well as leadership skills and either an MD or PhD in "a hard science."
FDA / USA Jobs / USA Jobs
Tags: OMP, Office of Medical Policy, Job, Director